Cargando…

ADAR1: “Editor-in-Chief” of Cytoplasmic Innate Immunity

Specialized receptors that recognize molecular patterns such as double stranded RNA duplexes—indicative of viral replication—are potent triggers of the innate immune system. Although their activation is beneficial during viral infection, RNA transcribed from endogenous mobile genetic elements may al...

Descripción completa

Detalles Bibliográficos
Autores principales: Lamers, Mart M., van den Hoogen, Bernadette G., Haagmans, Bart L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6669771/
https://www.ncbi.nlm.nih.gov/pubmed/31404141
http://dx.doi.org/10.3389/fimmu.2019.01763
_version_ 1783440449086685184
author Lamers, Mart M.
van den Hoogen, Bernadette G.
Haagmans, Bart L.
author_facet Lamers, Mart M.
van den Hoogen, Bernadette G.
Haagmans, Bart L.
author_sort Lamers, Mart M.
collection PubMed
description Specialized receptors that recognize molecular patterns such as double stranded RNA duplexes—indicative of viral replication—are potent triggers of the innate immune system. Although their activation is beneficial during viral infection, RNA transcribed from endogenous mobile genetic elements may also act as ligands potentially causing autoimmunity. Recent advances indicate that the adenosine deaminase ADAR1 through RNA editing is involved in dampening the canonical antiviral RIG-I-like receptor-, PKR-, and OAS-RNAse L pathways to prevent autoimmunity. However, this inhibitory effect must be overcome during viral infections. In this review we discuss ADAR1's critical role in balancing immune activation and self-tolerance.
format Online
Article
Text
id pubmed-6669771
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-66697712019-08-09 ADAR1: “Editor-in-Chief” of Cytoplasmic Innate Immunity Lamers, Mart M. van den Hoogen, Bernadette G. Haagmans, Bart L. Front Immunol Immunology Specialized receptors that recognize molecular patterns such as double stranded RNA duplexes—indicative of viral replication—are potent triggers of the innate immune system. Although their activation is beneficial during viral infection, RNA transcribed from endogenous mobile genetic elements may also act as ligands potentially causing autoimmunity. Recent advances indicate that the adenosine deaminase ADAR1 through RNA editing is involved in dampening the canonical antiviral RIG-I-like receptor-, PKR-, and OAS-RNAse L pathways to prevent autoimmunity. However, this inhibitory effect must be overcome during viral infections. In this review we discuss ADAR1's critical role in balancing immune activation and self-tolerance. Frontiers Media S.A. 2019-07-25 /pmc/articles/PMC6669771/ /pubmed/31404141 http://dx.doi.org/10.3389/fimmu.2019.01763 Text en Copyright © 2019 Lamers, van den Hoogen and Haagmans. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Lamers, Mart M.
van den Hoogen, Bernadette G.
Haagmans, Bart L.
ADAR1: “Editor-in-Chief” of Cytoplasmic Innate Immunity
title ADAR1: “Editor-in-Chief” of Cytoplasmic Innate Immunity
title_full ADAR1: “Editor-in-Chief” of Cytoplasmic Innate Immunity
title_fullStr ADAR1: “Editor-in-Chief” of Cytoplasmic Innate Immunity
title_full_unstemmed ADAR1: “Editor-in-Chief” of Cytoplasmic Innate Immunity
title_short ADAR1: “Editor-in-Chief” of Cytoplasmic Innate Immunity
title_sort adar1: “editor-in-chief” of cytoplasmic innate immunity
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6669771/
https://www.ncbi.nlm.nih.gov/pubmed/31404141
http://dx.doi.org/10.3389/fimmu.2019.01763
work_keys_str_mv AT lamersmartm adar1editorinchiefofcytoplasmicinnateimmunity
AT vandenhoogenbernadetteg adar1editorinchiefofcytoplasmicinnateimmunity
AT haagmansbartl adar1editorinchiefofcytoplasmicinnateimmunity